Medical oncologist Philip A. Philip, MD, PhD, has joined Henry Ford Cancer Institute (HFCI) as Director of Gastrointestinal Oncology and Neuroendocrine Oncology, Medical Director of Research and Clinical Care Integration, and co-leader of the Henry Ford Pancreatic Cancer Center (HFPCC). Dr. Philip has led numerous breakthroughs over the course of his career in the areas of pancreatic cancer and neuroendocrine tumors.
Philip A. Philip, MD, PhD
Steven Kalkanis, MD
“Dr. Philip is a prolific researcher and skillful clinician with extensive experience in an academic medical center environment,” said Steven Kalkanis, MD, Chief Executive Officer of the Henry Ford Medical Group and Chief Academic Officer at Henry Ford Health System. “He is a strong leader with a proven track record demonstrating his deep commitment to providing outstanding patient care and achieving scientific breakthroughs that are continuing to help advance research in many aspects of pancreatic cancer.”
Dr. Philip will join HFCI from the Karmanos Cancer Institute, where he has served in multiple leadership roles over the past 25 years. He will continue to serve as tenured Professor of Oncology at Wayne State University School of Medicine.
David Kwon, MD
Howard Crawford, PhD
Dr. Philip will co-lead the HFPCC alongside David Kwon, MD, pancreatic cancer surgeon and Clinical Director of the HFPCC, and Howard Crawford, PhD, who joined the HFPCC in 2020 as Scientific Director from the University of Michigan.
